The healthcare conglomerate said it expects full-year sales of $80.5 billion to $81.3 billion, compared with a prior range of $81.0 billion to $81.8 billion.
Shares of Fortis Healthcare rose by 4 per cent after its board approved Rs 4,000-crore offer from Malaysia's IHH Healthcare for 31.1 per cent stake in the healthcare company.
Fortis Healthcare today said its board has picked Malaysia's IHH Healthcare to take control of India's second-largest hospital chain, ending months of takeover battle.
After months of searching for an investor, cash-strapped Fortis Healthcare today said its board has unanimously accepted a binding offer from Malaysia's IHH Healthcare Berhad to invest Rs 4,000 crore in it by way of preferential allotment at Rs 170 per share.
Indian market will react to June IIP data which was at 8-month low at 3.2%. June CPI Data inched higher at 5% vs 4.87% MoM.
Zydus Cadila has received final approval from the US health regulator to market Zolmitriptan tablets, used to relieve headache, pain, and other migraine symptom.
Cash-strapped Fortis Healthcare, which is in the process of finding a new investor, today said its board will meet on July 13 to consider raising funds through issue of securities on a preferential allotment basis.
Naidu said the country is making steady progress in healthcare status though there are several challenges to be addressed.
Independent auditor of the Fortis Healthcare, Deloitte Haskins & Sells LLP today said the Board of Fortis Healthcare are unable at present to determine whether a fraud has occurred on the company.
Fortis Healthcare today said there has been no change in its audited financial results compared to the unaudited numbers reported on June 27, 2018.